Guardion Health Sciences Stock Target Price
Guardion Health Sciences fundamentals help investors to digest information that contributes to Guardion Health's financial success or failures. It also enables traders to predict the movement of Guardion Pink Sheet. The fundamental analysis module provides a way to measure Guardion Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Guardion Health pink sheet.
Guardion |
Guardion Target Price Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Guardion Health's direct or indirect competition against its Target Price to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Guardion Health could also be used in its relative valuation, which is a method of valuing Guardion Health by comparing valuation metrics of similar companies.Guardion Health is currently under evaluation in target price category among its peers.
Guardion Fundamentals
| Return On Equity | -0.5 | |||
| Return On Asset | -0.16 | |||
| Profit Margin | 0.52 % | |||
| Operating Margin | (18.75) % | |||
| Current Valuation | (987.33 K) | |||
| Shares Outstanding | 1.35 M | |||
| Shares Owned By Insiders | 1.30 % | |||
| Shares Owned By Institutions | 21.09 % | |||
| Number Of Shares Shorted | 22.26 K | |||
| Price To Earning | (0.71) X | |||
| Price To Book | 0.32 X | |||
| Price To Sales | 0.36 X | |||
| Revenue | 12.25 M | |||
| Gross Profit | 4.52 M | |||
| EBITDA | (3.92 M) | |||
| Net Income | 158.03 K | |||
| Cash And Equivalents | 14.23 M | |||
| Cash Per Share | 0.23 X | |||
| Total Debt | 3.77 M | |||
| Current Ratio | 11.28 X | |||
| Book Value Per Share | 10.71 X | |||
| Cash Flow From Operations | (4.37 M) | |||
| Short Ratio | 0.18 X | |||
| Earnings Per Share | (4.11) X | |||
| Target Price | 40.0 | |||
| Beta | 0.71 | |||
| Market Capitalization | 4.39 M | |||
| Total Asset | 11.92 M | |||
| Retained Earnings | (93.57 M) | |||
| Working Capital | 10.57 M | |||
| Current Asset | 12.8 M | |||
| Current Liabilities | 466.01 K | |||
| Annual Yield | 1.75 % | |||
| Net Asset | 11.92 M |
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Consideration for investing in Guardion Pink Sheet
If you are still planning to invest in Guardion Health Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Guardion Health's history and understand the potential risks before investing.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |